When mice harboring mammary tumors overexpressing the ERBB2 gene were crossed with CDK4 knockout mice, the resulting littermates did not develop tumors, and the acute loss of cyclin D1 or CDK4 proteins mediated via RNA interference attenuated tumor growth. The gene discussed is CDK4; the disease is breast cancer.